Hummingbird Bioscience is an innovative therapeutics company. Founded by Jerome Boyd-Kirkup and Piers Ingram in 2014, Hummingbird Bioscience is backed by investors that include Mirae Asset Venture Investment, SK holdings, Decheng Capital, Delian Capital, and Kiwoom Investment and is headquartered in Woodlands.